EcoDrugPlus

24-Dehydrocholesterol Reductase

Ensembl ID : ENSPSNG00000001327
Gene Symbol: DHCR24
3 Cross references
208 Possible Orthologues:

3-Hydroxy-3-Methylglutaryl-Coa Reductase

Ensembl ID : ENSPSNG00000006005
Gene Symbol: HMGCR
3 Cross references
270 Possible Orthologues:

3-Phosphoinositide Dependent Protein Kinase 1

Ensembl ID : ENSPSNG00000018250
Gene Symbol: PDPK1
3 Cross references
240 Possible Orthologues:

4-Hydroxyphenylpyruvate Dioxygenase

Ensembl ID : ENSPSNG00000007502
Gene Symbol: HPD
3 Cross references
204 Possible Orthologues:

40s Ribosomal Protein S12

Ensembl ID : ENSPSNG00000018246
Gene Symbol: LOC116762404
2 Cross references
56 Possible Orthologues:

40s Ribosomal Protein S15-Like

Ensembl ID : ENSPSNG00000006962
Gene Symbol: LOC116743001
2 Cross references
121 Possible Orthologues:

40s Ribosomal Protein S26

Ensembl ID : ENSPSNG00000010622
Gene Symbol: LOC116756669
2 Cross references
200 Possible Orthologues:

40s Ribosomal Protein S26-Like

Ensembl ID : ENSPSNG00000004106
Gene Symbol: LOC116750641
2 Cross references
145 Possible Orthologues:

40s Ribosomal Protein S3a-Like

Ensembl ID : ENSPSNG00000004681
Gene Symbol: LOC116758081
2 Cross references
172 Possible Orthologues:

40s Ribosomal Protein S7-Like

Ensembl ID : ENSPSNG00000000874
Gene Symbol: LOC116755731
2 Cross references
175 Possible Orthologues:

5'-Nucleotidase Ecto

Ensembl ID : ENSPSNG00000006916
Gene Symbol: NT5E
3 Cross references
249 Possible Orthologues:

5-Hydroxytryptamine Receptor 1a

Ensembl ID : ENSPSNG00000011163
Gene Symbol: HTR1A
3 Cross references
147 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).